dr. musher on immunotherapy versus tkis in hcc
Published 4 years ago • 298 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
1:03
dr. musher discusses the role of regorafenib in advanced hcc
-
1:17
dr. musher on current therapies for hcc
-
1:15
dr. huey on the importance of patient selection in hcc
-
1:45
dr. musher on investigational combination therapies in hcc
-
1:21
unmet needs in immunotherapy for hepatocellular carcinoma
-
1:57
recent immunotherapy advances in hcc management
-
4:14
imbrave150 trial: frontline treatment of advanced hcc
-
44:44
the increasing role of immunotherapy in the management of hcc
-
1:09
dr. lee on combining tkis with immunotherapy in mrcc
-
59:49
immunotherapy for hepatocellular carcinoma: promises and challenges
-
9:52
factors in selecting immunotherapy or tki inhibition
-
2:02
immunotherapy approaches in hepatocellular carcinoma
-
1:56
immunotherapy and chemotherapy: what's the difference?
-
1:55
dr. kim on combining immunotherapy and tkis in metastatic rcc
-
0:51
what is immunotherapy?
-
5:46
treating her2 mbc: immunotherapy and tkis
-
2:47
immunotherapy plus tkis for the treatment of crc
-
5:13
the role of immunotherapy in treating r/r mhcc
-
0:12
why immunotherapy should be standard in cancer care